Friday Pfizer Inc (PFE) $PFE opened at 31.02 hitting the high price of 31.06 and a day low of 30.55 with a total volume of 41,708,402. PFE had a previous close of 31.15 and has been seeing an average volume of 34,580,574.
Overall Average: 40% Sell
Recent stock forum discussions about PFE http://investorshangout.com/search?q=PFE&...mp;yt0=Go!
Buffalo Wild Wings' Wild Earnings, Twitter's Egg, Big M&A Drama, and the Week in Review
Jack Kramer and Nick Martell, The Motley Fool - Motley Fool - Sat May 03, 6:00PM CDT
Before you toss back a couple of Dos Equis before Cinco de Mayo (or some Buds before the all-American Kentucky Derby), check out what pushed the Dow up to its first record high of 2014 this past week -- and anticipation of the big,... (full story)
This Week in Biotech: Merger Mania Continues
Sean Williams, The Motley Fool - Motley Fool - Sat May 03, 12:15PM CDT
With the SPDR S&P Biotech Index up 23% over the trailing-12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and... (full story)
Meet Lung Cancer's New Enemy
Todd Campbell, The Motley Fool - Motley Fool - Sat May 03, 9:00AM CDT
Novartis just won the FDA's approval for its new lung cancer drug, Zykadia, months ahead of schedule. The FDA's move reflects the significant need for new therapies designed to treat less common causes of cancer. In this case, the approval gives... (full story)
'Fast Money' Recap: Bullish or Bearish on Bonds?
at The Street - Sat May 03, 4:00AM CDT
The trading panel discussed energy companies and Berkshire Hathaway earnings. (full story)
The Dow Misses a New Record as Merck, Pfizer, and J&J Lag
Dan Caplinger, The Motley Fool - Motley Fool - Fri May 02, 8:05PM CDT
After climbing to potential new-record levels at the open, the Dow Jones Industrials closed down almost 46 points on Friday, with trouble in Ukraine heating up and prompting an emergency meeting of the U.N. Security Council in response to violence... (full story)
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri May 02, 7:24PM CDT
Today's move into the red caught investors by surprise because the economy seems to be improving. Here's what Cramer will be watching next week. (full story)
Most active New York Stock Exchange-traded stocks
AP - Fri May 02, 5:03PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading: (full story)
Final Glance: Pharmaceuticals companies
AP - Fri May 02, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading: (full story)
AstraZeneca rejects sweetened Pfizer takeover bid
By DANICA KIRKA and LINDA A. JOHNSON - AP - Fri May 02, 4:36PM CDT
LONDON (AP) — Pharmaceutical giant Pfizer said Friday that it hasn't given up on a deal after British drugmaker AstraZeneca flatly rejected its latest takeover bid, worth $106 billion. (full story)
Stocks finish lower on mixed earnings, Ukraine
By BERNARD CONDON - AP - Fri May 02, 4:29PM CDT
NEW YORK (AP) — The stock market ended lower on Friday as a surprisingly strong report on job gains failed to impress investors. (full story)
1 Comment
Medical Devices Face Onslaught Of Pricing Pressure
at Investor's Business Daily - Fri May 02, 4:26PM CDT
Makers of medical devices are coming under increasing pressure, owing to a fundamental power shift in American medicine favoring insurance companies, hospitals and their patients. The change, according to Moty Avisar, president of medical systems... (full story)
Business Highlights
By The Associated Press - AP - Fri May 02, 4:15PM CDT
___ (full story)
Will Pfizer (PFE) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 02, 3:45PM CDT
Pfizer (PFE) has an Earnings ESP of -1.82% with a Zacks Rank #4 (Sell). (full story)
Pfizer Set to Possibly Rebound After Yesterday's Selloff of 1.28%
Comtex SmarTrend(R) - Fri May 02, 3:40PM CDT
Pfizer (NYSE
FE) traded in a range yesterday that spanned from a low of $30.55 to a high of $31.06. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $30.94 on volume of 41.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. (full story)
After Yesterday's Decline of 1.28%, Pfizer Offers Investors Better Value
Comtex SmarTrend(R) - Fri May 02, 3:40PM CDT
Pfizer (NYSE FE) traded in a range yesterday that spanned from a low of $30.55 to a high of $31.06. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $30.94 on volume of 41.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. (full story)
Why Pfizer Will Move the Dow Monday
Dan Caplinger, The Motley Fool - Motley Fool - Fri May 02, 3:30PM CDT
On Friday, the Dow Jones Industrials started out the day in record territory, with a big surge in April employment creating positive economic momentum for the stock market. But news that Russian President Vladimir Putin had called for a meeting... (full story)
Stocks Drop as Jobs Pop Is Offset by Troubling Details
at The Street - Fri May 02, 3:23PM CDT
U.S. stocks close lower Friday, erasing early gains after April's jobs report shows a lower work force participation rate. The United Nations is holding an emergency meeting over Ukraine as tensions rise in the region. (full story)
Big Pharma Deals Send Dow Lower
Travis Hoium, The Motley Fool - Motley Fool - Fri May 02, 2:30PM CDT
On a day when the Department of Labor issued a seemingly great jobs report, the Dow Jones Industrial Average was off 0.28% late in trading. A big reason is the index's two big pharma companies, Merck and Pfizer , falling as acquisition and... (full story)
Pfizer Inc. Earnings: Can They Grow Without AstraZeneca?
Dan Caplinger, The Motley Fool - Motley Fool - Fri May 02, 1:30PM CDT
On Monday, Pfizer will release its quarterly report, and despite strong markets over the past year, the pharmaceutical giant's shares have stayed in a tight range. Investors are pondering how Pfizer can best foster growth in an increasingly... (full story)
AstraZeneca Nixes New Bid As Pfizer Woos British PM
at Investor's Business Daily - Fri May 02, 1:11PM CDT
British big pharma AstraZeneca (AZN) turned down a second takeover bid from U.S. counterpart Pfizer (PFE) Friday, saying that the $106 billion offer was still too low. Pfizer's stock dropped nearly 2%, while AstraZeneca's held steady on the stock... (full story)
Overall Average: 40% Sell
Recent stock forum discussions about PFE http://investorshangout.com/search?q=PFE&...mp;yt0=Go!
Buffalo Wild Wings' Wild Earnings, Twitter's Egg, Big M&A Drama, and the Week in Review
Jack Kramer and Nick Martell, The Motley Fool - Motley Fool - Sat May 03, 6:00PM CDT
Before you toss back a couple of Dos Equis before Cinco de Mayo (or some Buds before the all-American Kentucky Derby), check out what pushed the Dow up to its first record high of 2014 this past week -- and anticipation of the big,... (full story)
This Week in Biotech: Merger Mania Continues
Sean Williams, The Motley Fool - Motley Fool - Sat May 03, 12:15PM CDT
With the SPDR S&P Biotech Index up 23% over the trailing-12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and... (full story)
Meet Lung Cancer's New Enemy
Todd Campbell, The Motley Fool - Motley Fool - Sat May 03, 9:00AM CDT
Novartis just won the FDA's approval for its new lung cancer drug, Zykadia, months ahead of schedule. The FDA's move reflects the significant need for new therapies designed to treat less common causes of cancer. In this case, the approval gives... (full story)
'Fast Money' Recap: Bullish or Bearish on Bonds?
at The Street - Sat May 03, 4:00AM CDT
The trading panel discussed energy companies and Berkshire Hathaway earnings. (full story)
The Dow Misses a New Record as Merck, Pfizer, and J&J Lag
Dan Caplinger, The Motley Fool - Motley Fool - Fri May 02, 8:05PM CDT
After climbing to potential new-record levels at the open, the Dow Jones Industrials closed down almost 46 points on Friday, with trouble in Ukraine heating up and prompting an emergency meeting of the U.N. Security Council in response to violence... (full story)
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri May 02, 7:24PM CDT
Today's move into the red caught investors by surprise because the economy seems to be improving. Here's what Cramer will be watching next week. (full story)
Most active New York Stock Exchange-traded stocks
AP - Fri May 02, 5:03PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading: (full story)
Final Glance: Pharmaceuticals companies
AP - Fri May 02, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading: (full story)
AstraZeneca rejects sweetened Pfizer takeover bid
By DANICA KIRKA and LINDA A. JOHNSON - AP - Fri May 02, 4:36PM CDT
LONDON (AP) — Pharmaceutical giant Pfizer said Friday that it hasn't given up on a deal after British drugmaker AstraZeneca flatly rejected its latest takeover bid, worth $106 billion. (full story)
Stocks finish lower on mixed earnings, Ukraine
By BERNARD CONDON - AP - Fri May 02, 4:29PM CDT
NEW YORK (AP) — The stock market ended lower on Friday as a surprisingly strong report on job gains failed to impress investors. (full story)
1 Comment
Medical Devices Face Onslaught Of Pricing Pressure
at Investor's Business Daily - Fri May 02, 4:26PM CDT
Makers of medical devices are coming under increasing pressure, owing to a fundamental power shift in American medicine favoring insurance companies, hospitals and their patients. The change, according to Moty Avisar, president of medical systems... (full story)
Business Highlights
By The Associated Press - AP - Fri May 02, 4:15PM CDT
___ (full story)
Will Pfizer (PFE) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 02, 3:45PM CDT
Pfizer (PFE) has an Earnings ESP of -1.82% with a Zacks Rank #4 (Sell). (full story)
Pfizer Set to Possibly Rebound After Yesterday's Selloff of 1.28%
Comtex SmarTrend(R) - Fri May 02, 3:40PM CDT
Pfizer (NYSE
FE) traded in a range yesterday that spanned from a low of $30.55 to a high of $31.06. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $30.94 on volume of 41.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. (full story) After Yesterday's Decline of 1.28%, Pfizer Offers Investors Better Value
Comtex SmarTrend(R) - Fri May 02, 3:40PM CDT
Pfizer (NYSE
FE) traded in a range yesterday that spanned from a low of $30.55 to a high of $31.06. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $30.94 on volume of 41.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. (full story) Why Pfizer Will Move the Dow Monday
Dan Caplinger, The Motley Fool - Motley Fool - Fri May 02, 3:30PM CDT
On Friday, the Dow Jones Industrials started out the day in record territory, with a big surge in April employment creating positive economic momentum for the stock market. But news that Russian President Vladimir Putin had called for a meeting... (full story)
Stocks Drop as Jobs Pop Is Offset by Troubling Details
at The Street - Fri May 02, 3:23PM CDT
U.S. stocks close lower Friday, erasing early gains after April's jobs report shows a lower work force participation rate. The United Nations is holding an emergency meeting over Ukraine as tensions rise in the region. (full story)
Big Pharma Deals Send Dow Lower
Travis Hoium, The Motley Fool - Motley Fool - Fri May 02, 2:30PM CDT
On a day when the Department of Labor issued a seemingly great jobs report, the Dow Jones Industrial Average was off 0.28% late in trading. A big reason is the index's two big pharma companies, Merck and Pfizer , falling as acquisition and... (full story)
Pfizer Inc. Earnings: Can They Grow Without AstraZeneca?
Dan Caplinger, The Motley Fool - Motley Fool - Fri May 02, 1:30PM CDT
On Monday, Pfizer will release its quarterly report, and despite strong markets over the past year, the pharmaceutical giant's shares have stayed in a tight range. Investors are pondering how Pfizer can best foster growth in an increasingly... (full story)
AstraZeneca Nixes New Bid As Pfizer Woos British PM
at Investor's Business Daily - Fri May 02, 1:11PM CDT
British big pharma AstraZeneca (AZN) turned down a second takeover bid from U.S. counterpart Pfizer (PFE) Friday, saying that the $106 billion offer was still too low. Pfizer's stock dropped nearly 2%, while AstraZeneca's held steady on the stock... (full story)
